Vessels that encapsulate tumour clusters vascular pattern in hepatocellular carcinoma

被引:17
作者
Liu, Ken [1 ,2 ,3 ,7 ]
Dennis, Claude [1 ]
Prince, David S. [4 ]
Marsh-Wakefield, Felix [3 ,5 ]
Santhakumar, Cositha [1 ,3 ,5 ]
Gamble, Jennifer R. [6 ]
Strasser, Simone I. [1 ,2 ]
McCaughan, Geoffrey W. [1 ,2 ,3 ]
机构
[1] Royal Prince Alfred Hosp, Australian Natl Liver Transplant Unit, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[3] Centenary Inst, Liver Injury & Canc Program, Sydney, NSW, Australia
[4] Liverpool Hosp, Dept Gastroenterol, Sydney, NSW, Australia
[5] Univ Sydney, Human Immunol Lab, Sydney, NSW, Australia
[6] Centenary Inst, Ctr Endothelium, Vasc Biol Program, Sydney, NSW, Australia
[7] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Level 9,Missenden Rd, Camperdown, NSW 2050, Australia
关键词
Vessels that encapsulate tumour clusters (VETC); angiogenesis; biomarker; metastasis; liver transplantation; epithelial mesenchymal transition (EMT); EPITHELIAL-MESENCHYMAL TRANSITION; ANTIANGIOGENIC THERAPY; MICROVESSEL DENSITY; METASTASIS; SORAFENIB; ANGIOGENESIS; BEVACIZUMAB; PREDICTOR; INVASION; PLUS;
D O I
10.1016/j.jhepr.2023.100792
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Vessels that encapsulate tumour clusters (VETC) is a distinct histologic vascular pattern associated with a novel mechanism of metastasis. First described in human cancers in 2004, its prevalence and prognostic significance in hepatocellular carcinoma (HCC) has only been appreciated in the past decade with a rapidly increasing body of literature. A robust biomarker of aggressive disease, the VETC pattern is easy to recognise but relies on histologic examination of tumour tissue for its diagnosis. Radiological recognition of the VETC pattern is an area of active research and is becoming increasingly accurate. As a prognostic marker, VETC has consistently proven to be an independent predictor of disease recurrence and overall survival in patients with HCC undergoing resection and liver transplantation. It can also guide treatment by predicting response to other therapies such as transarterial chemoembolisation and sorafenib. Without prospective randomised-controlled trials or routine evaluation of VETC in clinical practice, there are currently no firm treatment recommendations for VETC-positive tumours, although some perspectives are provided in this review based on the latest knowledge of their pathogenesis - a complex interplay between tumour angiogenesis and the immune microenvironment. Nevertheless, VETC has great potential as a future biomarker that could take us one step closer to precision medicine for HCC. & COPY; 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma
    Marsh-Wakefield, Felix
    Ferguson, Angela L.
    Liu, Ken
    Santhakumar, Cositha
    McCaughan, Geoffrey
    Palendira, Umaimainthan
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [32] EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis
    Gu, Fangming
    Yuan, Shengxian
    Liu, Lei
    Zhu, Peng
    Yang, Yuan
    Pan, Zeya
    Zhou, Weiping
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) : 4208 - 4216
  • [33] PET imaging of tumor vascular normalization in hepatocellular carcinoma
    An, Shuxian
    Liu, Jianjun
    Huang, Gang
    Kang, Fei
    Wei, Weijun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 2940 - 2943
  • [34] Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1
    Dong, Yinying
    Xie, Xiaoying
    Wang, Zhiming
    Hu, Chao
    Zheng, Qiongdan
    Wang, Yaohui
    Chen, Rongxin
    Xue, Tongchun
    Chen, Jie
    Gao, Dongmei
    Wu, Weizhong
    Ren, Zhenggang
    Cui, Jiefeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 444 (03) : 427 - 432
  • [35] Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival
    Jia, Jin-Bin
    Zhuang, Peng-Yuan
    Sun, Hui-Chuan
    Zhang, Ju-Bo
    Zhang, Wei
    Zhu, Xiao-Dong
    Xiong, Yu-Quan
    Xu, Hua-Xiang
    Tang, Zhao-You
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (06) : 847 - 854
  • [36] Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma
    Kuczynski, Elizabeth A.
    Yin, Melissa
    Bar-Zion, Avinoam
    Lee, Christina R.
    Butz, Henriett
    Man, Shan
    Daley, Frances
    Vermeulen, Peter B.
    Yousef, George M.
    Foster, F. Stuart
    Reynolds, Andrew R.
    Kerbel, Robert S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (08):
  • [37] Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma
    Fan, Yanfen
    Yu, Yixing
    Wang, Ximing
    Hu, Mengjie
    Du, Mingzhan
    Guo, Lingchuan
    Sun, Shifang
    Hu, Chunhong
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 349 - 359
  • [38] The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA
    Fang, Min
    Yuan, Jingping
    Chen, Mengyuan
    Sun, Zongwen
    Liu, Lulu
    Cheng, Guoping
    Ying, Hangjie
    Yang, Shifeng
    Chen, Ming
    ONCOLOGY LETTERS, 2018, 15 (04) : 4805 - 4812
  • [39] Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma
    Bao, Meiyan
    Chen, Zhiao
    Xu, Yongfen
    Zhao, Yingjun
    Zha, Ruopeng
    Huang, Shenglin
    Liu, Li
    Chen, Taoyang
    Li, Jinjun
    Tu, Hong
    He, Xianghuo
    LIVER INTERNATIONAL, 2012, 32 (02) : 331 - 338
  • [40] Molecular pattern of lncRNAs in hepatocellular carcinoma
    Mai, Haoming
    Zhou, Bin
    Liu, Li
    Yang, Fu
    Conran, Carly
    Ji, Yuan
    Hou, Jinlin
    Jiang, Deke
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)